Adam Luber, MD
Dermatology · Phoenix, AZNPI 1396155867
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 56.5% of the total. Reporting peaked in 2024 at $2,789 and has fallen 78.0% since, to $614 in 2025.
Across 57 payments — averaging $71.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$2K
- AbbVie$428
- Sanofi$257
- Pfizer$156
- Lilly USA, LLC$121
- Sun Pharmaceutical Industries Inc.$116
- plus $690 from 13 others
Across 197 payments — averaging $1210.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$183K
- AbbVie$46K
- Sanofi US Services Inc.$5K
- Amgen$5K
What the payments were for
- Consulting fees$2,13553%
- Food & beverage$1,70142%
- Education$2296%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $2,298 |
| AbbVie(2 entities) | 7 | $428 |
| Sanofi | 4 | $257 |
| Pfizer | 3 | $156 |
| Lilly USA, LLC | 5 | $121 |
| Sun Pharmaceutical Industries Inc. | 4 | $116 |
| Organon | 5 | $109 |
| UCB, Inc. | 3 | $92 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Johnson & Johnson | 3 | $61 |
| E.r. Squibb & Sons, L.L.C. | 3 | $60 |
| Dermavant Sciences, Inc. | 3 | $54 |
| Arcutis Biotherapeutics, Inc. | 2 | $49 |
| LEO Pharma Inc. | 2 | $49 |
| Regeneron | 1 | $44 |
| Almirall LLC | 2 | $38 |
| Botanix SB Inc | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Incyte Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$2,135
- EUCRISA$120
- BOTOX COSMETIC$113
- Skyrizi$100
How this compares
$4,065 in reported general payments places this provider in the 60th percentile of 305 dermatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 23 | $106,337 |
| Fluorouracil | 202 | $13,871 |
| Clobetasol Propionate | 89 | $4,673 |
| Ketoconazole | 267 | $4,005 |
| Triamcinolone Acetonide | 225 | $1,800 |
| Clindamycin Phosphate | 37 | $1,316 |
| ValacyclovirValacyclovir Hcl | 36 | $1,213 |
| Metronidazole | 15 | $1,195 |
| Azelaic Acid | 12 | $970 |
| Ciclopirox | 15 | $751 |
| Ammonium Lactate | 27 | $657 |
| Hydrocortisone | 92 | $492 |
| Doxycycline Monohydrate | 32 | $419 |
| Imiquimod | 14 | $407 |
| Mupirocin | 49 | $327 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Phoenix
- Lindsay AckermanPhoenix$1.6M
- Nathalie ZeitouniPhoenix$584K
- Carsten HamannPhoenix$364K
- Michael CrandallPhoenix$153K
- Sadra JazayeriPhoenix$115K
- Cynthia PricePhoenix$76K
- William KoPhoenix$66K
- Dathan HamannPhoenix$56K
- Peter SigalPhoenix$30K
- Xuan NguyenPhoenix$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.